Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $1.9 million.

  • Bio-Techne's Change in Inventory fell 7823.3% to $1.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $22.4 million, marking a year-over-year increase of 3682.34%. This contributed to the annual value of $18.1 million for FY2025, which is 2763.98% up from last year.
  • Bio-Techne's Change in Inventory amounted to $1.9 million in Q4 2025, which was down 7823.3% from $14.0 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Change in Inventory peaked at $16.0 million during Q2 2022, and registered a low of -$173000.0 during Q1 2025.
  • For the 5-year period, Bio-Techne's Change in Inventory averaged around $5.9 million, with its median value being $4.9 million (2023).
  • As far as peak fluctuations go, Bio-Techne's Change in Inventory soared by 51382.05% in 2021, and later crashed by 88636.36% in 2025.
  • Bio-Techne's Change in Inventory (Quarter) stood at $5.7 million in 2021, then soared by 34.24% to $7.7 million in 2022, then tumbled by 43.19% to $4.4 million in 2023, then skyrocketed by 104.27% to $8.9 million in 2024, then crashed by 78.23% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q4 2025, $14.0 million for Q3 2025, and $6.6 million during Q2 2025.